In 2023, the pharmaceutical industry's export market share in China stood at 3.25%. The forecasted data indicates a gradual upward trend from 2024 onwards, starting at 3.3% and reaching 3.46% by 2028. Year-on-year variations show a consistent increase of approximately 1.52% annually from 2024 to 2028. The Compound Annual Growth Rate (CAGR) over this period is 1.55%, denoting a steady but modest growth in export market share.
For future trends to watch, consider the following:
- Increasing R&D investments and innovations in the Chinese pharmaceutical industry.
- Influence of global regulatory changes and international trade policies.
- Impact of emerging markets and competitive dynamics in the global pharmaceutical landscape.
- Evolution of healthcare demands and ageing population in China.
- Adoption of advanced technologies such as biopharmaceuticals and personalized medicine.
